“Design, Molecular Docking, Synthesis, and Pharmacological Evaluation of Nabumetone-Derived Oxadiazole and Thiadiazole Schiff Bases as Potential EGFR Inhibitors for NSCLC” (2026) Al Mustansiriyah Journal of Pharmaceutical Sciences, 25(5), pp. 973–991. doi:10.32947/ajps.v25i5.1318.